Mitsubishi UFJ Asset Management’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
Other funds holding WVE
RCM
GP
MC
DCM
6CM
RAM
Mitsubishi UFJ Asset Management's WVE Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its Wave Life Sciences (WVE) stake by 10% in Q2 2026, buying an estimated $22.9K and bringing the position to 36,473 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.
Mitsubishi UFJ Asset Management first reported a position in WVE in Q3 2018 and has held it in 16 quarters since. The position peaked at $540K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.
- Mitsubishi UFJ Asset Management held 36,473 shares of Wave Life Sciences worth $212K as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 3,450 Wave Life Sciences shares in Q2 2026, an estimated $22.9K.
- Wave Life Sciences made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1013 holding.
- Mitsubishi UFJ Asset Management first reported a position in Wave Life Sciences in Q3 2018 and has held it in 16 quarters since.
- Mitsubishi UFJ Asset Management's Wave Life Sciences position peaked at $540K in Q4 2025.
- 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.